Researchers have developed a new blood test using infrared spectroscopy to detect even a single lung cancer cell in real time ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care ...

Scientists in the UK have developed a breakthrough blood test that can detect lung cancer one cell at a time using FT-IR ...

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

An X-ray can help healthcare professionals find non-small cell lung cancer tumors and gain a deeper understanding of them. The healthcare team will also need other imaging and tests for a complete ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) today released a study of a complex clinical case in which CyPath® Lung’s real-time assessment of the lung ...

Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test ...

Researchers have developed a groundbreaking blood test using Fourier Transform Infrared (FT-IR) microspectroscopy to detect a ...

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Study by BAMC ...